• Salinomycin: Polyether Ionophore Antibiotic in HCC Assays

  2026-05-10

  Salinomycin’s dual action as an ABC transporter and Wnt/β-catenin pathway inhibitor makes it a cornerstone for advanced hepatocellular carcinoma research. Explore how optimized protocols and troubleshooting insights with APExBIO’s Salinomycin enable high-precision apoptosis and proliferation assays, validated by cutting-edge systems biology approaches.

• Palbociclib (PD0332991): Precision CDK4/6 Inhibition in Canc

  2026-05-09

  Unlock the full experimental potential of Palbociclib (PD0332991) in advanced cancer research, from robust G0/G1 cell-cycle arrest assays to cutting-edge assembloid applications. Discover workflow refinements and troubleshooting strategies that elevate reproducibility and translational value in breast cancer and RCC studies.

• Aurora A Kinase Regulates Trained Immunity via SAM Metabolis

  2026-05-08

  This study reveals Aurora kinase A (AurA) as a central regulator of trained immunity in innate immune cells through control of S-adenosylmethionine (SAM) metabolism. By connecting AurA activity to chromatin accessibility and epigenetic programming, the findings offer new insight into oncogenesis, cancer biology, and the immunometabolic axes relevant for tumor progression and therapeutic intervention.

• Plk1-Dependent Regulation of p31comet in Mitotic Checkpoint

  2026-05-08

  This study elucidates how Polo-like kinase 1 (Plk1) regulates p31comet-mediated disassembly of mitotic checkpoint complexes, a critical process for accurate chromosome segregation. By demonstrating Plk1's phosphorylation of p31comet on S102 and subsequent modulation of spindle assembly checkpoint resolution, the work clarifies a longstanding gap in our understanding of checkpoint inactivation and highlights new avenues for precision cell cycle research.

• MLN8237 (Alisertib): Applied Strategies in Cancer Biology As

  2026-05-07

  MLN8237 (Alisertib) empowers researchers to dissect Aurora A kinase-driven oncogenesis with exceptional selectivity, enabling robust apoptosis induction and tumor growth inhibition assays. This guide details advanced workflows, troubleshooting strategies, and novel assay designs, leveraging the latest molecular insights and APExBIO quality.

• WZ4003: Precision NUAK1/2 Inhibitor Workflows for Cancer and

  2026-05-07

  WZ4003 is a highly selective NUAK1/2 inhibitor, enabling researchers to dissect cell migration, proliferation, and tau phosphorylation pathways with unprecedented specificity. This article offers detailed workflows, troubleshooting strategies, and practical protocol parameters, translating recent findings in cancer and neurodegeneration models into actionable laboratory guidance.

• KPT-330 (Selinexor): Translational Advances in Nuclear Expor

  2026-05-06

  Explore how KPT-330 (Selinexor) is reshaping cancer research as a selective CRM1 inhibitor. This article delivers a deep dive into mechanistic insights, protocol optimization, and the translational impact of recent breakthroughs, with a focus on practical assay decisions and unique research strategies.

• Quercetin (N1841): Mechanistic Insights as a PI3K Inhibitor

  2026-05-06

  Quercetin, a dietary flavonoid and PI3K inhibitor, demonstrates robust anti-inflammatory and antineoplastic effects in preclinical research. Its ability to modulate key intracellular signaling pathways and promote apoptosis underpins its widespread adoption in cancer and neuroinflammation studies.

• Myriocin as a Serine Palmitoyltransferase Inhibitor: Workflo

  2026-05-05

  Myriocin empowers researchers to dissect sphingolipid metabolism and cell cycle regulation with precision, thanks to its potent, selective inhibition of serine palmitoyltransferase. This guide translates cutting-edge findings and validated protocols into actionable steps for cancer, immunology, and cardiovascular research, with troubleshooting tips and data-backed optimization strategies.

• Nocodazole: Precision Microtubule Polymerization Inhibitor W

  2026-05-05

  Nocodazole stands out as a potent, reversible microtubule polymerization inhibitor, enabling high-resolution dissection of cell cycle regulation and microtubule dynamics. This guide details evidence-based protocols, advanced applications in translational research, and troubleshooting strategies for maximizing assay reproducibility and impact in cancer research.

• Trametinib (GSK1120212): Targeting B-RAF–MEK–ERK Axis in Pai

  2026-05-04

  Explore how Trametinib (GSK1120212) enables advanced modulation of the B-RAF–MEK–ERK pathway, extending its value beyond oncology into neural pain sensitization research. Unlock protocol strategies and mechanistic insights grounded in new primary literature.

• Trametinib (GSK1120212): Reliable MEK1/2 Inhibition in Cell

  2026-05-04

  This article addresses challenges in cell viability and proliferation assays by showcasing Trametinib (GSK1120212), SKU A3018, as a rigorously validated MEK1/2 inhibitor. Integrating recent evidence and best practices, we guide biomedical researchers on maximizing reproducibility and interpretability in MAPK/ERK pathway studies with high-quality reagents from APExBIO.

• PD 0332991 (Palbociclib) HCl: Rethinking CDK4/6 Inhibition

  2026-05-03

  This thought-leadership article for translational researchers explores the mechanistic foundation, strategic workflow guidance, and evolving research frontiers enabled by PD 0332991 (Palbociclib) HCl. We bridge rigorous evidence, including new gene-senescence links, with actionable protocols and a vision for next-generation cancer research.

• IWR-1-endo: Precision Tool for Advanced Wnt Pathway Dissecti

  2026-05-02

  Explore how IWR-1-endo, a potent Wnt signaling inhibitor, enables rigorous mechanistic studies and next-generation assay development. This article reveals unique insights on Axin-scaffolded complex stabilization and cross-domain research strategies.

• Mifepristone (RU486) in Cancer and Repro Biology: Applied Pr

  2026-05-01

  Mifepristone (RU486) from APExBIO is a high-purity progesterone receptor antagonist enabling reproducible inhibition of tumor growth and modulation of reproductive function. This in-depth guide translates recent mechanistic insights and published workflows into actionable protocols, troubleshooting advice, and comparative advantages for advanced oncology and reproductive biology research.

405 records 9/27 page Previous Next First page 上5页 678910 下5页 Last page